Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Renal Failure

  Free Subscription


Articles published in Curr Opin Nephrol Hypertens

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    June 2018
  1. MACDOUGALL IC
    Iron therapy for managing anaemia in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Jun 13. doi: 10.1097/MNH.0000000000000436.
    PubMed     Text format     Abstract available


    May 2018
  2. JELKMANN W
    Activin receptor ligand traps in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 May 29. doi: 10.1097/MNH.0000000000000433.
    PubMed     Text format     Abstract available


  3. DUBIN RF
    Application of echocardiographic data in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 May 16. doi: 10.1097/MNH.0000000000000419.
    PubMed     Text format     Abstract available


  4. GUPTA N, Wish JB
    Erythropoietin mimetic peptides and erythropoietin fusion proteins for treating anemia of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 May 4. doi: 10.1097/MNH.0000000000000430.
    PubMed     Text format     Abstract available


  5. DEKKER MJE, Kooman JP
    Fluid status assessment in hemodialysis patients and the association with outcome: review of recent literature.
    Curr Opin Nephrol Hypertens. 2018;27:188-193.
    PubMed     Text format     Abstract available


    April 2018
  6. STRAUSSER SA, Nakano D, Souma T
    Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response.
    Curr Opin Nephrol Hypertens. 2018 Apr 26. doi: 10.1097/MNH.0000000000000424.
    PubMed     Text format     Abstract available


  7. MOE SM
    Rationale to reduce calcium intake in adult patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Apr 26. doi: 10.1097/MNH.0000000000000416.
    PubMed     Text format     Abstract available


  8. SCIALLA JJ
    Evidence basis for integrated management of mineral metabolism in patients with end-stage renal disease.
    Curr Opin Nephrol Hypertens. 2018 Apr 6. doi: 10.1097/MNH.0000000000000417.
    PubMed     Text format     Abstract available


    March 2018
  9. STELLER WAGNER MARTINS C, Jorgetti V, Moyses RMA
    Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Mar 31. doi: 10.1097/MNH.0000000000000418.
    PubMed     Text format     Abstract available


  10. ASHLEY J, Sood MM
    Novel oral anticoagulants in chronic kidney disease: ready for prime time?
    Curr Opin Nephrol Hypertens. 2018 Mar 22. doi: 10.1097/MNH.0000000000000410.
    PubMed     Text format     Abstract available


  11. CONNELLY K, Collister D, Tangri N
    Fracture risk and treatment in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Mar 15. doi: 10.1097/MNH.0000000000000411.
    PubMed     Text format     Abstract available


    February 2018
  12. LI T, Xie Y, Al-Aly Z
    The association of proton pump inhibitors and chronic kidney disease: cause or confounding?
    Curr Opin Nephrol Hypertens. 2018 Feb 9. doi: 10.1097/MNH.0000000000000406.
    PubMed     Text format     Abstract available


    January 2018
  13. HAAS M
    Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts.
    Curr Opin Nephrol Hypertens. 2018 Jan 2. doi: 10.1097/MNH.0000000000000398.
    PubMed     Text format     Abstract available


    December 2017
  14. RAO M, Jaber BL, Balakrishnan VS
    Chronic kidney disease and acquired mitochondrial myopathy.
    Curr Opin Nephrol Hypertens. 2017 Dec 20. doi: 10.1097/MNH.0000000000000393.
    PubMed     Text format     Abstract available


    November 2017
  15. KRAUT JA, Madias NE
    Retarding progression of chronic kidney disease: use of modalities that counter acid retention.
    Curr Opin Nephrol Hypertens. 2017 Nov 14. doi: 10.1097/MNH.0000000000000386.
    PubMed     Text format     Abstract available


  16. SCHMIDT RJ
    Incorporating supportive care into the hemodialysis unit.
    Curr Opin Nephrol Hypertens. 2017;26:530-536.
    PubMed     Text format     Abstract available


    October 2017
  17. WALTHER CP, Chandra A, Navaneethan SD
    Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Oct 16. doi: 10.1097/MNH.0000000000000375.
    PubMed     Text format     Abstract available


    September 2017
  18. GOLPER TA
    Incremental dialysis: review of recent literature.
    Curr Opin Nephrol Hypertens. 2017 Sep 11. doi: 10.1097/MNH.0000000000000362.
    PubMed     Text format     Abstract available


  19. SY J, Johansen KL
    The impact of frailty on outcomes in dialysis.
    Curr Opin Nephrol Hypertens. 2017 Sep 9. doi: 10.1097/MNH.0000000000000364.
    PubMed     Text format     Abstract available


    August 2017
  20. GEORGIANOS PI, Agarwal R
    Blood pressure in hemodialysis: targets?
    Curr Opin Nephrol Hypertens. 2017 Aug 21. doi: 10.1097/MNH.0000000000000359.
    PubMed     Text format     Abstract available


  21. WONNACOTT A, Bowen T, Fraser DJ
    MicroRNAs as biomarkers in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Aug 12. doi: 10.1097/MNH.0000000000000356.
    PubMed     Text format     Abstract available


    March 2017
  22. HSU RK, Powe NR
    Recent trends in the prevalence of chronic kidney disease: not the same old song.
    Curr Opin Nephrol Hypertens. 2017 Mar 17. doi: 10.1097/MNH.0000000000000315.
    PubMed     Text format     Abstract available


  23. COLLISTER D, Rigatto C, Tangri N
    Anemia management in chronic kidney disease and dialysis: a narrative review.
    Curr Opin Nephrol Hypertens. 2017 Mar 16. doi: 10.1097/MNH.0000000000000317.
    PubMed     Text format     Abstract available


    February 2017
  24. DAVIS JL, Davison SN
    Hard choices, better outcomes: a review of shared decision-making and patient decision aids around dialysis initiation and conservative kidney management.
    Curr Opin Nephrol Hypertens. 2017 Feb 16. doi: 10.1097/MNH.0000000000000321.
    PubMed     Text format     Abstract available


  25. COWAN AC, Gharib EG, Weir MA
    Advances in the management of hyperkalemia in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Feb 15. doi: 10.1097/MNH.0000000000000320.
    PubMed     Text format     Abstract available


  26. MOORTHI RN, Avin KG
    Clinical relevance of sarcopenia in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Feb 13. doi: 10.1097/MNH.0000000000000318.
    PubMed     Text format     Abstract available


  27. RUZICKA M, Hiremath S
    Intensive blood pressure lowering in chronic kidney disease: the time has come.
    Curr Opin Nephrol Hypertens. 2017 Feb 13. doi: 10.1097/MNH.0000000000000316.
    PubMed     Text format     Abstract available


    November 2016
  28. GORDON CE, Nader C
    Evolving therapies for hepatitis C virus in chronic kidney disease: the beginning of a new era.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


    October 2016
  29. DHAYBI OA, Bakris G
    Mineralocorticoid antagonists in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


    September 2016
  30. MAVRAKANAS TA, Charytan DM
    Cardiovascular complications in chronic dialysis patients.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  31. CUNHA CB, D'Agata EM
    Implementing an antimicrobial stewardship program in out-patient dialysis units.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  32. TUMMALAPALLI L, Nadkarni GN, Coca SG
    Biomarkers for predicting outcomes in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


    August 2016
  33. LEE MB, Bargman JM
    Myths in peritoneal dialysis.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  34. KALRA PA, Bhandari S
    Safety of intravenous iron use in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  35. WOJCIECHOWSKI D, Vincenti F
    Current status of costimulatory blockade in renal transplantation.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  36. MATSUSHITA K, Ballew SH, Coresh J
    Cardiovascular risk prediction in people with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  37. AHMAD S, Bromberg JS
    Current status of the microbiome in renal transplantation.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  38. FRASER SD, Taal MW
    Multimorbidity in people with chronic kidney disease: implications for outcomes and treatment.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


    May 2016
  39. GINSBERG C, Ix JH
    Nicotinamide and phosphate homeostasis in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  40. LYTVYN Y, Bjornstad P, Pun N, Cherney DZ, et al
    New and old agents in the management of diabetic nephropathy.
    Curr Opin Nephrol Hypertens. 2016;25:232-9.
    PubMed     Text format     Abstract available


    November 2015
  41. TOWNSEND RR, Reese PP, Lim MA
    Should living kidney donors with hypertension be considered for organ donation?
    Curr Opin Nephrol Hypertens. 2015;24:594-601.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: